Allworth Financial LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allworth Financial LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,089
+14.0%
511
+24.3%
0.00%
Q2 2023$12,355
+287.4%
411
+367.0%
0.00%
Q1 2023$3,189
+49.0%
88
+46.7%
0.00%
Q4 2022$2,140
+114.0%
60
+50.0%
0.00%
Q3 2022$1,0000.0%400.0%0.00%
Q2 2022$1,0000.0%400.0%0.00%
Q1 2022$1,0000.0%400.0%0.00%
Q4 2021$1,0000.0%400.0%0.00%
Q3 2021$1,0000.0%400.0%0.00%
Q2 2021$1,0000.0%400.0%0.00%
Q1 2021$1,0000.0%400.0%0.00%
Q4 2020$1,0000.0%400.0%0.00%
Q3 2020$1,0000.0%400.0%0.00%
Q2 2020$1,0000.0%40
-2.4%
0.00%
Q1 2020$1,0000.0%410.0%0.00%
Q4 2019$1,0000.0%410.0%0.00%
Q3 2019$1,0000.0%410.0%0.00%
Q2 2019$1,0000.0%410.0%0.00%
Q1 2019$1,0000.0%41
+2.5%
0.00%
Q4 2018$1,000
-50.0%
400.0%0.00%
Q3 2018$2,0000.0%400.0%0.00%
Q2 2018$2,0000.0%400.0%0.00%
Q1 2018$2,000400.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 921,962$33,402,6835.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 423,500$15,326,4654.28%
ARMISTICE CAPITAL, LLC 4,350,000$157,600,5002.27%
S&T BANK/PA 223,775$8,1071.46%
Aristotle Capital Boston, LLC 1,155,149$41,851,0711.29%
Tributary Capital Management, LLC 353,671$12,813,5001.19%
Bridge City Capital, LLC 62,790$2,274,8821.14%
RICE HALL JAMES & ASSOCIATES, LLC 551,285$19,973,0561.14%
Intrinsic Edge Capital Management LLC 289,704$10,495,9761.05%
Parkman Healthcare Partners LLC 131,878$4,777,9401.04%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders